Ever thought a probiotic could help manage blood sugar by stimulating GLP-1?
Dr. Colleen Cutcliffe, CEO of Pendulum Therapeutics, is merging biotech rigor with consumer-friendly safety to tackle type 2 diabetes before it even starts.
Pendulum - who've raised $150M and have early backing from Mayo Clinic - have a flagship medical food named Pendulum Glucose Control, which is clinically proven to lower A1C. Just ask Halle Berry, who saw her own levels drop and came on board as an investor after it helped her diabetes!
Hundreds of thousands of spine fusions are performed each year, but implant choice is still often limited to standard sizes.
Personalis is betting that detecting relapse at the molecular level, before it becomes radiographically obvious, can change how cancer is monitored and managed.
The machinery that governs gene expression is being targeted to beat cancer.
Millions of T1DM patients worldwide are on lifelong insulin and constant monitoring. But what if we could switch off the immune attack causing the disease?
